Johnson and Johnson's Latest Ethical Misadventures: Settled Kickback Allegations, Reportedly Concealed Knowledge of Adverse Effects of a " Sacred Cow " Product
Giant pharmaceutical/ biotechnology/ device company Johnson& Johnson has its famous" credo " which starts withWe believe our first responsibility is to the doctors, nurses and patients, to mothers and fathers and all others who use our products and services. In meeting their needs everything we do must be of high quality..Nonetheless, the company has a long history of ethical misadventures (lookhere, and see appendix below). Now late in 2018, we note two more Johnson& Johnson misadventures. In chronological order,$360 Million Settlement of Allegations of Kickbacks to Medicare/ Medicaid Patients to...
Source: Health Care Renewal - December 15, 2018 Category: Health Management Tags: adulterated drugs adverse effects deception impunity Johnson and Johnson kickbacks legal settlements Source Type: blogs
Personalized Physical Therapy at Home Using Real Specialists and 3D Camera
Artificial hip and knee replacements require quite a bit of physical therapy post surgery to achieve the desired results. In many places and for many people, a rehab clinic may be too far away or time too short to receive regular therapy. At home exercises, even using virtual coaches, are helpful but they probably can’t be as motivating or effective as a real therapist. At the Fraunhofer Institute for Open Communication Systems in Germany, researchers have built a system that allows therapists to effectively become virtual coaches while being able to assess their patients and how they perform various exercises.
TheÂ...
Source: Medgadget - June 12, 2018 Category: Medical Devices Authors: Editors Tags: Orthopedic Surgery Rehab Source Type: blogs
Will Trump Repeal Medical Device Taxes?
Part of President Obama’s landmark health care bill, the Affordable Care Act, imposed a federal tax on medical devices. That tax was temporarily suspended in January 2016, which allowed some medical device companies (i.e., OrthoPediatrics Corp. based in Northern Indiana) to hire more workers. The CEO of OrthoPediatrics is hoping that President Donald Trump, together with Congress, will turn the temporary suspension into a permanent repeal.
OrthoPediatrics Instituted a Headcount Freeze
OrthoPediatrics, founded in 2006, develops and markets implantable orthopedic devices, such as metal plates that can be attached ...
Source: Policy and Medicine - March 23, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
An interview with a deep brain stimulation patient: “I’m worried about getting water in the holes in my head”
By Christian Jarrett
Deep brain stimulation is a medical procedure that involves implanting electrodes permanently into the brain and using them to alter the functioning of specific neural networks. A battery inserted subcutaneously in the chest provides the device with power. One application of the technology is as a treatment for Parkinson’s Disease, a neurodegenerative condition that causes tremors and difficulties moving. While the treatment can bring about an impressive alleviation of symptoms, research suggests that Parkinson’s patients often struggle to adjust psychologically. Now a case study publish...
Source: BPS RESEARCH DIGEST - January 26, 2017 Category: Psychiatry & Psychology Authors: BPS Research Digest Tags: Brain Health Qualitative Source Type: blogs
Despite Long Record of Misadventures, Johnson and Johnson to Receive Award for " Ethical Leadership?! "
What does it take for a big pharmaceutical/ device/ biotechnology company to get an ethics award?Reported by Sheila Kaplan at Stat (but for subscribers only), and first noticed by Carl Elliott and justdiscussed on his Fear and Loathing in Bioethics blog, it appears that the giant Johnson and Johnson pharma/ device/ biotech company will get an award in " ethical leadership " from and " organization called Fellowships at Auschwitz for the Study of Professional Ethics, or FASPE. "The Stat report, quoted by Dr Elliott, stated:FASPE Chairman David Goldman, an attorney in New York, said he wasaware of the pharma giant ’s vario...
Source: Health Care Renewal - December 14, 2016 Category: Health Management Tags: crime health care ethics Johnson and Johnson legal settlements Source Type: blogs
The Wages of Sin - a Small Illustration of How Executives Can Personally Profit from Bad Corporate Behavior in Health Care
Conclusions < /b > < br / > < br / > So this case appears to be a step forward, in that not all the people who apparently authorized, directed, or implemented the bad behavior could escape any negative consequences. & nbsp; Keep in mind, however, that no one above the two convicted executives, no one at Johnson and Johnson who decided to acquire Acclarent, and let it continue its previous activities, seemed to suffer any negative consequences. & nbsp; How much money those executives might have received in response to the revenues that the new subsidiary brought in is unknown. < br / > < br / > In conclusion, this case show...
Source: Health Care Renewal - July 27, 2016 Category: Health Management Tags: adulterated devices crime Ethicon impunity Johnson and Johnson legal settlements medical devices perverse incentives Source Type: blogs
Change happens best when it’s done with clinicians and not to them
Like a pro golfer swears by a certain brand of clubs or a marathon runner has a chosen make of shoes, surgeons can form strong loyalties to the tools of their craft. Preferences for these items — such as artificial hips and knees, surgical screws, stents, pacemakers and other implants — develop over time, perhaps out of habit or acquired during their training.
Of course, surgeons should have what they need to be at the top of their trade. But the downside of too much variation is that it can drive up the costs of procedures for hospitals, insurers and even patients. When a hospital carries seven brands of the ...
Source: Kevin, M.D. - Medical Weblog - December 9, 2015 Category: Journals (General) Authors: Peter Pronovost, MD, PhD Tags: Policy Hospital Source Type: blogs
Cost, Value & Tools
By PETER PRONOVOST, MD
Like a pro golfer swears by a certain brand of clubs or a marathon runner has a chosen make of shoes, surgeons can form strong loyalties to the tools of their craft. Preferences for these items — such as artificial hips and knees, surgical screws, stents, pacemakers and other implants — develop over time, perhaps out of habit or acquired during their training.
Of course, surgeons should have what they need to be at the top of their trade. But the downside of too much variation is that it can drive up the costs of procedures for hospitals, insurers and even patients. When a hospital carries se...
Source: The Health Care Blog - November 29, 2015 Category: Consumer Health News Authors: John Irvine Tags: THCB Costs Johns Hopkins Peter Pronovost Quality Tools Value Source Type: blogs
Same Old, Same Old - Johnson and Johnson Settles Charges it Concealed Adverse Effects of Risperdal, Vaginal Mesh Device, Pleads Guilty to Selling Adulterated Tylenol, Announces CEO Got 48% Raise to $25 Million
We have devoted a lot of bytes over the years to the stream of allegations and ethical questions about Johnson and Johnson, the giant pharmaceutical/ biotechnology/ device company, and resulting legal actions. Meanwhile, the company has bestowed a gushing stream of money on its top executives. Its almost spring, 2015, and it seems nothing has changed.Johnson and Johnson's Latest Legal MisadventuresJury Verdict that Company Concealed Harms of Risperdal Let us start with the latest legal news about J&J. In late February, 2015, as reported on the PharmaLot blog by Ed Silverman,In a setback to Johnson &am...
Source: Health Care Renewal - March 18, 2015 Category: Health Management Tags: adulterated drugs adverse effects Alex Gorsky crime deception Johnson and Johnson legal settlements manufacturing problems William Weldon Source Type: blogs
LITFL Review 152
The LITFL Review is your regular and reliable source for the highest highlights, sneakiest sneak peeks and loudest shout-outs from the webbed world of emergency medicine and critical care. Each week the LITFL team casts the spotlight on the blogosphere’s best and brightest and deliver a bite-sized chuck of FOAM.
Welcome to the 152nd edition, brought to you by:
Anand Swaminathan [AS] (EM Lyceum, iTeachEM)
Brent Thoma [BT] (BoringEM and Academic Life in EM)
Chris Connolly [CC]
Chris Nickson [CN] ( iTeachEM, RAGE, INTENSIVE and SMACC)
Joe-Anthony Rotella [JAR]
Kane Guthrie [KG]
Mat Goebel [MG]
Segun Olusany...
Source: Life in the Fast Lane - October 14, 2014 Category: Emergency Medicine Authors: Anand Swaminathan Tags: Review LITFL R/V Source Type: blogs
Medtronic Sued by 1,000 Infuse Patients
by John FauberMedtronic said about 1,000 people have sued the company over its bone morphogenetic protein-2 (BMP-2) product, Infuse, and that many more lawsuits may be coming.In addition, several states now are looking into sales and marketing practices involving Infuse, which is used in spine surgery.In a statement, company spokesperson Cindy Resman said the cases are in early procedural stages, and none have resulted in a finding of liability against Medtronic.Some court rulings have led to dismissals and others have limited claims."Medtronic stands behind Infuse bone graft and will vigorously defend it in cour...
Source: PharmaGossip - March 5, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs
Open Payments: A Matter Of Maintaining Trust
For decades, it’s been no secret that some physicians have financial relationships with health care manufacturing companies. For example, a pharmaceutical firm might fund a cardiologist at an academic medical center to research an experimental medication for lowering cholesterol. Or, an orthopedic surgeon might receive a consulting fee from a medical device manufacturer for counsel about an artificial hip.
These widespread collaborations can involve gifts, meals, speaking fees, travel support, or payment for research activities. The good news is that these joint efforts have led to the discovery, design, and developmen...
Source: Health Affairs Blog - February 27, 2014 Category: Health Medicine and Bioethics Commentators Authors: Anita Griner Tags: All Categories Business of Health Care Health Law Health Reform Medicaid Medicare Physicians Policy Public Opinion Source Type: blogs
The Greedy Leading the Greedy - Multimillionaire Former Johnson and Johnson CEO Approved Huge Compensation for JP Morgan Chase CEO After Company Paid $20 Billion in Legal Settlements
JP Morgan Chase CEO Got Huge Raise Despite Company's Recent Huge Legal Settlements The current compensation set by the board of directors of JP Morgan Chase for CEO Jamie Dimon, $20 million a year, has attracted some attention (e.g., see this commentary by Matt Taibbi), especially given the contrast between his raise and the $20 billion or so the company had to pay out last year in settlements of allegations of unethical practices. A New York Times opinion piece rushed to Mr Dimon's defensein the world of executive compensation, especially when viewed from the rarefied perspective of other chief executives, and more...
Source: Health Care Renewal - January 31, 2014 Category: Health Medicine and Bioethics Commentators Tags: boards of directors executive compensation finance impunity Johnson and Johnson JPMorgan Chase legal settlements William Weldon Source Type: blogs
Augmenting lifelong performance with deliberate practice
With Willing Spirit, a Reprise for Ailey Dancers (The New York Times):
“The voice on the phone belonged to Masazumi Chaya, the associate artistic director of Alvin Ailey American Dance Theater, and he had a startling proposition. Would she — Elizabeth Roxas-Dobrish, 55 years old, former Ailey superstar and current artificial-hip owner — come out of retirement to dance at a special performance on New Year’s Eve? …“Are you kidding me?” she responded. No, he was not kidding, and eventually the answer was yes, she would do it. And it was yes, too, for a handful of other Ailey alumni who received similar callsâ€...
Source: SharpBrains - December 26, 2013 Category: Neurologists Authors: SharpBrains Tags: Education & Lifelong Learning Health & Wellness dance deliberate practice retirement Source Type: blogs
The Camel's Aching Back - Johnson and Johnson and Novartis Fined 16 Million Euro for "Anticompetitive" Scheme to Delay Generic Fentanyl
Legal and regulatory actions unfavorable for giant pharmaceutical, biotechnology and device company Johnson and Johnson just keep coming. We last discussed such a story only two weeks ago here. The Latest Case This latest story got only desultory US coverage from the wire services. The most complete version is in the European Commission press release. The basics were:The European Commission has imposed fines of € 10 798 000 on the US pharmaceutical company Johnson & Johnson (J&J) and € 5 493 000 on Novartis of Switzerland. In July 2005, their respective Dutch subsidiaries concluded an ...
Source: Health Care Renewal - December 17, 2013 Category: Health Medicine and Bioethics Commentators Tags: antitrust Fentanyl Johnson and Johnson mission-hostile management narcotics Netherlands Novartis restraint of competition Source Type: blogs
